Literature DB >> 509874

Effect of indomethacin on blood pressure in the normotensive unanaesthetized rabbit: possible relation to prostaglandin synthesis inhibition.

J Colina-Chourio, J C McGiff, A Nasjletti.   

Abstract

1. To test the hypothesis that endogenous prostaglandins contribute to the regulation of blood pressure, we studied the effect of an inhibitor of prostaglandin synthesis, indomethacin, on mean aortic blood pressure in the normotensive, unanaesthetized rabbit. 2. Daily administration of indomethacin at 42 mumol/kg subcutaneously, but not of vehicle only, for 14 consecutive days, elevated the average mean arterial pressure in seven rabbits from 88 +/- 3 mmHg on the last day of the control period to 105 +/- 3 mmHg (P less than 0.01) and 107 +/- 2 mmHg (P less than 0.01) on days 6 and 14 of indomethacin treatment respectively, and reduced the urinary excretion of prostaglandin-like substance from 1.06 +/- 0.26 to 0.17 +/- 0.05 nmol of prostaglandin E2 equivalents/day (P less than 0.05; n = 5). Neither indomethacin nor the vehicle affected the intake of water, the 24 h urine volume, the cumulative difference between sodium intake and urinary sodium excretion, or the plasma volume. 3. The results of the study are compatible with the hypothesis that one or more prostaglandins contribute to maintain normotension in the rabbit and that reduction in prostaglandin biosynthesis may cuase blood pressure to rise.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 509874     DOI: 10.1042/cs0570359

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

1.  Arachidonic acid metabolites, hypertension and arteriosclerosis.

Authors:  P C Weber; W Siess; B Scherer; E Held; H Witzgall; R Lorenz
Journal:  Klin Wochenschr       Date:  1982-05-17

2.  Reversal by prostaglandin E2 infusion of the effects of indomethacin on the excretion of nitrogenous compounds in the rat.

Authors:  D J Rowe; G Gedeon
Journal:  Br J Exp Pathol       Date:  1983-06

3.  Low-dose Iloprost infusion improves insulin action and non-oxidative glucose metabolism in hypertensive patients.

Authors:  G Paolisso; A Gambardella; F Saccomanno; G Varricchio; A D'Amore; M Varricchio
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.